AK

Arun Kumar

Active Director Director DIN 08809080
DIN 08809080 First appointment Jul 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Arun Kumar

Data last updated:

Arun Kumar is a Director at Bonus-Salus Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Bonus-Salus Pharmaceuticals Private Limited reported revenue of ₹18.3 Lakh (FY 2023).

DIN 08809080
Primary Designation Director
Industry Chemicals
First Appointment 25 Jul 2020
Oldest Company Age 6 yrs
Largest company Bonus-Salus Pharmaceuticals Private Limited · ₹18.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jul 20202020₹18.3 Lakh (FY 2023)Active

Board colleagues of Arun Kumar

Directorship timeline

Open interactive timeline →
Bonus-Salus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arun Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Kumar

Arun Kumar currently holds 1 directorship: Bonus-Salus Pharmaceuticals Private Limited (Director, since 25 Jul 2020, revenue ₹18.3 Lakh (FY 2023)).

Arun Kumar was first appointed on 25 Jul 2020 as Director at Bonus-Salus Pharmaceuticals Private Limited.

The current boards of Arun Kumar's companies include Pankaj Kumar Garg (Bonus-Salus Pharmaceuticals Private Limited), Ramesh Kumar Aggarwal (Bonus-Salus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available